Children and caregiver proxy quality of life from peanut oral immunotherapy trials

Abstract Background Health‐related quality of life (HRQoL) is significantly and substantially reduced in individuals with peanut allergy due to many factors associated with unanticipated or potentially fatal reactions. Further insight on the impact of peanut oral immunotherapy in managing peanut all...

Full description

Bibliographic Details
Main Authors: Audrey Dunn Galvin, Andrea Vereda, Pablo Rodríguez delRío, Antonella Muraro, Carla Jones, Robert Ryan, David Norval, Jennifer Jobrack, Aikaterini Anagnostou, Julie Wang
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Clinical and Translational Allergy
Subjects:
Online Access:https://doi.org/10.1002/clt2.12213